We are live on ! Find out more
MXCT icon

MaxCyte

116 hedge funds and large institutions have $303M invested in MaxCyte in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 36

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

2% more funds holding

Funds holding: 114116 (+2)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.11% less ownership

Funds ownership: 64.27%64.16% (-0.11%)

38% less capital invested

Capital invested by funds: $489M → $303M (-$186M)

78% less call options, than puts

Call options by funds: $5K | Put options by funds: $23K

Holders
116
Holders Change
+2
Holders Change %
+1.75%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
48
Reduced
36
Closed
10
Calls
$5K
Puts
$23K
Net Calls
-$18K
Net Calls Change
-$16K
Name Holding Trade Value Shares
Change
Change in
Stake
Point72 Asset Management
51
Point72 Asset Management
Connecticut
$464K +$307K +66,800 +195%
SEI Investments
52
SEI Investments
Pennsylvania
$432K -$26K -5,648 -6%
Citigroup
53
Citigroup
New York
$396K +$128K +27,832 +46%
Renaissance Technologies
54
Renaissance Technologies
New York
$347K -$117K -25,500 -25%
CS
55
Credit Suisse
Switzerland
$340K +$80.2K +17,456 +31%
UBS Group
56
UBS Group
Switzerland
$326K +$86.7K +18,862 +36%
Bank of America
57
Bank of America
North Carolina
$323K -$76.3K -16,608 -19%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$322K -$92.6K -20,159 -22%
UBS AM
59
UBS AM
Illinois
$308K
AllianceBernstein
60
AllianceBernstein
Tennessee
$283K +$93.7K +20,390 +49%
Legal & General Group
61
Legal & General Group
United Kingdom
$275K +$144K +31,308 +110%
Ensign Peak Advisors
62
Ensign Peak Advisors
Utah
$268K
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
$223K -$81K -17,626 -27%
MIM
64
MetLife Investment Management
New Jersey
$219K -$38.9K -8,456 -15%
Chevy Chase Trust
65
Chevy Chase Trust
Maryland
$217K +$218K +47,381 New
GS
66
Gagnon Securities
New York
$212K +$42.3K +9,194 +25%
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
$197K -$387K -84,115 -66%
Franklin Resources
68
Franklin Resources
California
$197K +$197K +42,928 New
AIG
69
American International Group
New York
$193K -$2.15K -469 -1%
Mirae Asset Global Investments
70
Mirae Asset Global Investments
South Korea
$192K -$859 -187 -0.4%
HSBC Holdings
71
HSBC Holdings
United Kingdom
$180K -$712K -154,875 -79%
PP
72
PDT Partners
New York
$166K -$43.2K -9,403 -21%
Barclays
73
Barclays
United Kingdom
$160K -$197K -42,954 -55%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$159K +$5.74K +1,249 +4%
Wells Fargo
75
Wells Fargo
California
$154K +$82.1K +17,858 +114%

MXCT Hedge Fund Activity: Q2 2023 in Review

116 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q2 2023, worth a combined $303M — down 38% from $489M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MXCT positions and 10 closed out — a net gain of 2 holders — while 48 added to existing stakes and 36 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $5.79M. The largest seller was BAMCO Inc, exiting entirely with an estimated $9.84M sold.

  • 116 institutional investors held MaxCyte (MXCT) as of Q2 2023, up from 114 in Q1 2023.
  • Funds reported $303M of MaxCyte stock for Q2 2023, down 38% quarter-over-quarter.
  • 12 funds opened new MaxCyte positions in Q2 2023 and 10 closed out, a net change of +2 holders.
  • The largest MaxCyte buyer in Q2 2023 was Stonepine Capital Management, an estimated $5.79M added.
  • The largest MaxCyte seller in Q2 2023 was BAMCO Inc, an estimated $9.84M sold.

Based on aggregated 13F filings for Q2 2023.